FDG-PET/CT in oncology

被引：52
|
作者：
Krause, B. J. [1 ]
Beyer, T. [2 ]
Bockisch, A. [2 ]
Delbeke, D. [3 ]
Kotzerke, J. [4 ]
Minkov, V. [5 ]
Reiser, M. [6 ]
Willich, N. [7 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Nukl Med Klin & Poliklin, D-81675 Munich, Germany
[2] Univ Klinikum Essen, Klin Nukl Med, Essen, Germany
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[4] Univ Klinikum Dresden, Klin & Poliklin Nukl Med, Dresden, Germany
[5] Bundesamt Strahlenschutz, Salzgitter, Germany
[6] Univ Munich, Inst Klin Radiol, D-80539 Munich, Germany
[7] Univ Klinikum Munster, Klin & Poliklin Strahlentherapie Radioonkol, Munster, Germany
来源：
NUKLEARMEDIZIN-NUCLEAR MEDICINE | 2007年 / 46卷 / 06期
关键词：
guideline; FDG; PET/CT; oncology;
D O I：
10.3413/nukmed-282
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
FDG-PET/CT examinations combine metabolic and morphologic imaging within an integrated procedure. Over the post decade PET/CT imaging has gained wide clinical acceptance in the field of oncology. This FDG-PET/CT guideline focuses on indications, data acquisition and processing as well as documentation of FDG-PET/CT examinations in oncologic patients within a clinical and social context specific to Germany. Background information and definitions are followed by examples of clinical and research applications of FDG-PET/CT. Furthermore, protocols for CT scanning (low dose and contrast-enhanced CT) and PET emission imaging are discussed. Documentation and reporting of examinations are specified. Image interpretation criteria and sources of errors are discussed. Quality control for FOG and PET/CT-systems, qualification requirements of personnel as well as legal aspects are presented.
引用
收藏
页码：291 / 301
页数：11
相关论文
共 50 条
  • [1] FDG-PET/CT and SPECT/CT in oncology
    Kim, E. Edmund
    Yang, David J.
    Wong, Franklin C.
    [J]. CURRENT MEDICAL IMAGING, 2008, 4 (01) : 63 - 69
  • [2] Application of FDG-PET/CT in radiation oncology
    Li, Jun
    Xiao, Ying
    [J]. FRONTIERS IN ONCOLOGY, 2013, 3
  • [3] Oncology - "FDG-PET and immunomodulators"
    Fagart, A.
    Hubaut, M. -A.
    Tonnelet, D.
    [J]. MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2018, 42 (06): : 439 - 444
  • [4] The QIBA profile for quantitative FDG-PET/CT oncology imaging
    Kinahan, Paul
    Wahl, Richard
    Shao, Lingxiong
    Frank, Richard
    Perlman, Eric
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [5] The indications of FDG-PET in neck oncology
    Chisin, R
    Macapinlac, HA
    [J]. RADIOLOGIC CLINICS OF NORTH AMERICA, 2000, 38 (05) : 999 - +
  • [6] FDG-PET in oncology: techniques and applications
    Kletter, K
    Becherer, A
    [J]. RADIOLOGE, 1999, 39 (07): : 600 - 609
  • [7] Clinical applications of FDG-PET in oncology
    Czernin, J
    [J]. ACTA MEDICA AUSTRIACA, 2002, 29 (05) : 162 - 170
  • [8] Effect of dental implants on tracer distribution in FDG-PET and FDG-PET/CT
    Beyer, T
    Müller, SP
    Terschüren, B
    Stergar, H
    Kuehl, H
    Bockisch, A
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S409 - S409
  • [9] FDG-PET and PET/CT in Colorectal Cancer
    Lonneux, Max
    [J]. PET CLINICS, 2008, 3 (02) : 147 - +
  • [10] Detection of unexpected emergency diseases using FDG-PET/CT in oncology patients
    Toriihara, Akira
    Yamaga, Emi
    Nakadate, Masashi
    Oyama, Jun
    Tateishi, Ukihide
    [J]. JAPANESE JOURNAL OF RADIOLOGY, 2017, 35 (09) : 539 - 545
12345